Context-specific protection of TGFα null mice from osteoarthritis

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Usmani, Shirine E ^a   Ulici, Veronica ^a   Pest, Michael A ^a   Hill, Tracy L ^b   Welch, Ian D ^b   Beier, Frank ^a  

^a WESTERN UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; COLLAGENASE 3; EPITOPE; TRANSFORMING GROWTH FACTOR ALPHA;

AGING; ANIMAL; C57BL MOUSE; DEFICIENCY; DISEASE EXACERBATION; DISEASE MODEL; FEMALE; HETEROZYGOTE; INJURY; KNEE MENISCUS; KNOCKOUT MOUSE; MALE; METABOLISM; OSTEOARTHRITIS; PATHOLOGY;

AGING; ANIMALS; COLLAGEN TYPE II; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EPITOPES; FEMALE; HETEROZYGOTE; MALE; MATRIX METALLOPROTEINASE 13; MENISCI, TIBIAL; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOARTHRITIS; TRANSFORMING GROWTH FACTOR ALPHA; WOUNDS AND INJURIES;

EID: 84979781324     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep30434     Document Type: Article

References (57)

1. Salaffi, F., Carotti, M., Stancati, A., Grassi, W. Health-related quality of life in older adults with symptomatic hip and knee osteoarthritis: a comparison with matched healthy controls. Aging Clin Exp Res. 17, 255-263 (2005).
2. van der Waal, J. M., Terwee, C. B., van der Windt, D. A., Bouter, L. M., Dekker, J. The impact of non-traumatic hip and knee disorders on health-related quality of life as measured with the SF-36 or SF-12. A systematic review. Qual Life Res. 14, 1141-1155 (2005).
3. Zhang, W. et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 16, 137-162 (2008).
4. Bitton, R. The economic burden of osteoarthritis. Am J Manag Care. 15, S230-S235 (2009).
5. Woolf, A. D., Pfleger, B. Burden of major musculoskeletal conditions. Bull World Health Organ. 81, 646-656 (2003).
6. Hunter, D. J. Osteoarthritis. Best Pract Res Clin Rheumatol. 25, 801-814 (2011).
7. Krasnokutsky, S., Samuels, J., Abramson, S. B. Osteoarthritis in 2007. Bull NYU Hosp Jt Dis. 65, 222-228 (2007).
8. Aigner, T., Sachse, A., Gebhard, P. M., Roach, H. I. Osteoarthritis: pathobiology-targets and ways for therapeutic intervention. Adv Drug Deliv Rev. 58, 128-149 (2006).
9. Poole, A. R. et al. Composition and structure of articular cartilage: a template for tissue repair. Clin Orthop Relat Res. 391 Suppl, S26-S33 (2001).
10. Mueller, M. B., Tuan, R. S. Anabolic/Catabolic balance in pathogenesis of osteoarthritis: identifying molecular targets. PM R. 3, S3-11 (2011).
11. Qvist, P. et al. The disease modifying osteoarthritis drug (DMOAD): Is it in the horizon? Pharmacol Res. 58, 1-7 (2008).
12. Zhang, Y., Jordan, J. M. Epidemiology of osteoarthritis. Clin Geriatr Med. 26, 355-369 (2010).
13. Buckwalter, J. A., Martin, J. A. Osteoarthritis. Adv Drug Deliv Rev. 58, 150-167 (2006).
14. Muthuri, S. G., McWilliams, D. F., Doherty, M., Zhang, W. History of knee injuries and knee osteoarthritis: a meta-analysis of observational studies. Osteoarthritis Cartilage. 19, 1286-1293 (2011).
15. Anderson, D. D. et al. Post-traumatic osteoarthritis: improved understanding and opportunities for early intervention. J Orthop Res. 29, 802-809 (2011).
16. Makris, E. A., Hadidi, P., Athanasiou, K. A. The knee meniscus: structure-function, pathophysiology, current repair techniques, and prospects for regeneration. Biomaterials. 32, 7411-7431 (2011).
17. Englund, M., Roemer, F. W., Hayashi, D., Crema, M. D., Guermazi, A. Meniscus pathology, osteoarthritis and the treatment controversy. Nat Rev Rheumatol. 8, 412-419 (2012).
18. Loeser, R. F. Aging and osteoarthritis. Curr Opin Rheumatol. 23, 492-496 (2011).
19. Aigner, T., Richter, W. OA in 2011: Age-related OA-a concept emerging from infancy? Nat Rev Rheumatol. 8, 70-72 (2011).
20. Loeser, R. F. Molecular mechanisms of cartilage destruction: mechanics, inflammatory mediators, and aging collide. Arthritis Rheum. 54, 1357-1360 (2006).
21. Goekoop, R. J. et al. Determinants of absence of osteoarthritis in old age. Scand J Rheumatol. 40, 68-73 (2010).
22. Leong, D. J., Sun, H. B. Events in articular chondrocytes with aging. Curr Osteoporos Rep. 9, 196-201 (2011).
23. Appleton, C. T., Pitelka, V., Henry, J., Beier, F. Global analyses of gene expression in early experimental osteoarthritis. Arthritis Rheum. 56, 1854-1868 (2007).
24. Appleton, C. T. et al. Forced mobilization accelerates pathogenesis: characterization of a preclinical surgical model of osteoarthritis. Arthritis Res Ther. 9, R13 (2007).
25. Appleton, C. T., Usmani, S. E., Bernier, S. M., Aigner, T., Beier, F. Transforming growth factor alpha suppression of articular chondrocyte phenotype and Sox9 expression in a rat model of osteoarthritis. Arthritis Rheum. 56, 3693-3705 (2007).
26. Appleton, C. T., Usmani, S. E., Mort, J. S., Beier, F. Rho/ROCK and MEK/ERK activation by transforming growth factor-alpha induces articular cartilage degradation. Lab Invest. 90, 20-30 (2010).
27. Glasson, S. S., Blanchet, T. J., Morris, E. A. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthritis Cartilage. 15, 1061-1069 (2007).
28. Fang, H., Beier, F. Mouse models of osteoarthritis: modelling risk factors and assessing outcomes. Nat Rev Rheumatol. 10, 413-421 (2014).
29. Ma, H. L. et al. Osteoarthritis severity is sex dependent in a surgical mouse model. Osteoarthritis Cartilage. 15, 695-700 (2007).
30. Appleton, C. T. et al. Reduction in disease progression by inhibition of transforming growth factor alpha-CCL2 signaling in experimental posttraumatic osteoarthritis. Arthritis Rheumatol. 67, 2691-2701 (2015).
31. McNulty, M. A. et al. Histopathology of naturally occurring and surgically induced osteoarthritis in mice. Osteoarthritis Cartilage. 20, 949-956 (2012).
32. Loeser, R. F. et al. Microarray analysis reveals age-related differences in gene expression during the development of osteoarthritis in mice. Arthritis Rheum. 64, 705-717 (2011).
33. Kumar, V., Bustin, S. A., McKay, I. A. Transforming growth factor alpha. Cell Biol Int. 19, 373-388 (1995).
34. Davis, C. G. The many faces of epidermal growth factor repeats. New Biol. 2, 410-419 (1990).
35. Lee, D. C., Fenton, S. E., Berkowitz, E. A., Hissong, M. A. Transforming growth factor alpha: expression, regulation, and biological activities. Pharmacol Rev. 47, 51-85 (1995).
36. Zhang, Y. W. et al. Targeted disruption of Mig-6 in the mouse genome leads to early onset degenerative joint disease. Proc Natl Acad Sci USA 102, 11740-11745 (2005).
37. Jin, N., Gilbert, J. L., Broaddus, R. R., Demayo, F. J., Jeong, J. W. Generation of a Mig-6 conditional null allele. Genesis. 45, 716-721 (2007).
38. Hackel, P. O., Gishizky, M., Ullrich, A. Mig-6 is a negative regulator of the epidermal growth factor receptor signal. Biol Chem. 382, 1649-1662 (2001).
39. Xu, D., Makkinje, A., Kyriakis, J. M. Gene 33 is an endogenous inhibitor of epidermal growth factor (EGF) receptor signaling and mediates dexamethasone-induced suppression of EGF function. J Biol Chem. 280, 2924-2933 (2005).
40. Fiorentino, L. et al. Inhibition of ErbB-2 mitogenic and transforming activity by RALT, a mitogen-induced signal transducer which binds to the ErbB-2 kinase domain. Mol Cell Biol. 20, 7735-7750 (2000).
41. Zhang, X. et al. Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface. Nature. 450, 741-744 (2007).
42. Joiner, D. M. et al. Accelerated and Increased Joint Damage in Young Mice with Global Inactivation of Mitogen-Inducible Gene 6 (MIG-6) after Ligament and Meniscus Injury. Arthritis Res Ther. 16, R81 (2014).
43. Pest, M. A., Russell, B. A., Zhang, Y. W., Jeong, J. W., Beier, F. Disturbed cartilage and joint homeostasis resulting from a loss of mitogen-inducible gene 6 in a mouse model of joint dysfunction. Arthritis Rheumatol. 66, 2816-2827 (2014).
44. Staal, B., Williams, B. O., Beier, F., Vande Woude, G. F., Zhang, Y. W. Cartilage-specific deletion of Mig-6 results in osteoarthritislike disorder with excessive articular chondrocyte proliferation. Proc Natl Acad Sci USA. 111, 2590-2595 (2014).
45. Zhang, X. et al. Reduced EGFR signaling enhances cartilage destruction in a mouse osteoarthritis model. Bone Research. 2, 1-12 (2014).
46. Long, D. L., Ulici, V., Chubinskaya, S., Loeser, R. F. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is increased in osteoarthritis and regulates chondrocyte catabolic and anabolic activities. Osteoarthritis Cartilage. 23, 1523-1531 (2015).
47. Usmani, S. E. et al. Transforming growth factor alpha controls the transition from hypertrophic cartilage to bone during endochondral bone growth. Bone. 51, 131-141 (2012).
48. Sandell, L. J., Aigner, T. Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis. Arthritis Res. 3, 107-113 (2001).
49. Mann, G. B. et al. Mice with a null mutation of the TGF alpha gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell. 73, 249-261 (1993).
50. Ratneswaran, A. et al. Peroxisome proliferator-activated receptor delta promotes the progression of posttraumatic osteoarthritis in a mouse model. Arthritis Rheumatol. 67, 454-464 (2015).
51. Welch, I. D., Cowan, M. F., Beier, F., Underhill, T. M. The retinoic acid binding protein CRABP2 is increased in murine models of degenerative joint disease. Arthritis Res Ther. 11, R14 (2009).
52. Ulici, V. et al. The role of Akt1 in terminal stages of endochondral bone formation: angiogenesis and ossification. Bone. 45, 1133-1145 (2009).
53. Usmani, S. E., Appleton, C. T., Beier, F. Transforming growth factor-alpha induces endothelin receptor A expression in osteoarthritis. J Orthop Res. 30, 1391-1397 (2012).
54. Billinghurst, R. C. et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest. 99, 1534-1545 (1997).
55. Pritzker, K. P. et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage. 14, 13-29 (2006).
56. Appleton, C. T., McErlain, D. D., Henry, J. L., Holdsworth, D. W., Beier, F. Molecular and histological analysis of a new rat model of experimental knee osteoarthritis. Ann N Y Acad Sci. 1117, 165-174 (2007).
57. Glasson, S. S., Chambers, M. G., Van Den Berg, W. B., Little, C. B. The OARSI histopathology initiative-recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthritis Cartilage. 18 Suppl 3, S17-S23 (2010).